Lexaria Bioscience Corp. (LEXXW)
undefined
undefined%
At close: undefined
0.78
0.00%
After-hours Dec 13, 2024, 03:34 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06
Revenue 464.28K 226.21K 255.40K 722.74K 384.54K 222.61K 433.29K 63.64K 40.72K 14.70K 1.10M 1.36M 1.13M 362.47K 421.95K 900.79K 253.15K 20.31K 20.31K
Cost of Revenue 4.82K 31.50K 71.84K 175.35K 99.38K 22.89K 25.18K 29.75K 45.62K 29.88K 795.20K 783.27K 667.86K 273.62K 548.32K 912.75K 124.91K 93.32K 93.32K
Gross Profit 459.46K 194.71K 183.56K 547.39K 285.17K 199.72K 408.10K 33.89K -4.90K -15.18K 302.25K 574.49K 465.91K 88.86K -126.37K -11.96K 128.24K -73.01K -73.01K
Operating Income -5.75M -6.53M -7.38M -5.69M -3.89M -3.96M -6.60M -1.86M -1.22M -1.93M 294.06K -4.90K -259.50K -552.46K -753.67K -898.09K -1.05M -489.66K -35.14K
Interest Income 14.31K 43.19K - - - - - - - - - - - - 94.00 4.09K 18.09K 6.12K 6.12K
Pretax Income -5.80M -6.71M -7.38M -4.16M -4.08M -4.16M -6.61M -1.93M -1.28M -1.98M -1.87M -251.51K -538.23K -552.46K -753.67K -971.35K -1.05M -211.54K -75.58K
Net Income -5.80M -6.66M -7.27M -2.50M -4.03M -4.20M -6.60M -1.87M -1.21M -1.77M -1.87M -251.51K -538.23K -552.46K -753.57K -978.49K -1.06M -508.26K -75.72K
Selling & General & Admin 3.85M 3.06M 5.72M 4.97M 3.77M 3.64M 6.51M 1.84M 1.20M 1.76M 8.19K 565.35K 719.01K 467.23K 458.97K 479.45K 1.03M 141.51K 35.14K
Research & Development 2.36M 3.67M 1.84M 1.26M 387.07K 555.73K 492.86K 54.19K 9.02K 146.47K - - - - - - - - -
Other Expenses - - - - 112.75K 60.55K 2.31K -886 4.60K -22.66K - 14.04K 6.40K - 8.21K 1.27K 148.38K -2.99K -
Operating Expenses 6.21M 6.73M 7.57M 6.23M 4.27M 4.26M 7.01M 1.90M 1.21M 1.91M 8.19K 579.40K 725.41K 474.00K 467.18K 480.72K 1.18M 138.53K 35.14K
Interest Expense - - - - - - - 6.01K 2.25K 31.54K 267.36K 246.61K 278.73K 167.32K 160.12K 857.58K 4.71K 21.91K 21.91K
Selling & Marketing Expenses - - - - 204.28K 515.36K 489.06K 209.03K 185.46K 276.56K 8.19K 3.47K 40.92K 559.00 930.00 4.11K 20.07K 20.07K -
Cost & Expenses 6.22M 6.76M 7.64M 6.41M 4.37M 4.28M 7.03M 1.92M 1.26M 1.94M 803.40K 1.36M 1.39M 747.61K 1.02M 1.39M 1.30M 231.85K 35.14K
Income Tax - - -114.33K -1.66M -54.29K 39.62K -8.97K -54.17K -60.23K -181.23K 294.06K 246.61K 278.73K 167.32K -94 7.14K 1.04K 574.84K 40.59K
Shares Outstanding (Basic) 12.38M 6.61M 5.89M 4.39M 2.77M 2.59M 2.37M 1.96M 1.46M 1.32M 25.71M 602.48K 493.23K 451.94K 268.67K 219.28K 202.59K 160.87K 55.15K
Shares Outstanding (Diluted) 12.38M 6.61M 5.89M 4.39M 2.77M 2.59M 2.37M 1.96M 1.46M 1.32M 25.71M 602.48K 493.23K 451.94K 268.67K 219.28K 202.59K 160.87K 55.15K
EPS (Basic) -0.47 -1.01 -1.24 -0.57 -1.45 -1.62 -2.79 -0.95 -0.83 -1.34 -0.07 -0.42 -1.09 -1.22 -2.8 -4.46 -5.21 -3.16 -1.37
EPS (Diluted) -0.47 -1.01 -1.24 -0.57 -1.45 -1.62 -2.79 -0.95 -0.83 -1.34 -0.07 -0.42 -1.09 -1.22 -2.8 -4.46 -5.21 -3.16 -1.37
EBITDA -5.75M -6.39M -6.52M -5.58M -4.00M -4.10M -6.61M -1.92M -1.26M -1.95M 294.06K -35.30K 442.73K 111.12K -236.15K -244.37K -414.37K -891.03K -129.78K
Depreciation & Amortization - 145.40K 146.91K 147.60K 146.09K 60.55K 2.31K 1.49K 619.00 -22.66K 1.52M 456.60K 370.62K 122.16K 342.13K 453.12K 148.38K 81.76K 40.44K